The patients who actually take medications and live with their conditions are uniquely qualified to contribute to the drug development process. An evolving body of research regulations and approaches seek to ensure that patients' perspectives are incorporated into studies in a m…
The Southern California Clinical and Translational Science Institute, along with the UCLA Clinical and Translational Science Institute and the Los Angeles County (LAC) Department of Health Services (DHS) have partnered to fund and support interventions that will help enhance the…
An SC CTSI-supported pilot showed that "biologically meaningful" levels of light may ease depression symptoms for dementia patients living in long-term care communities. Implications of the research could contribute to the design of healthier buildings for everyone.
The scholars will begin their course work on June 1, 2019 to develop critical clinical and translational research skills.
Zippy follows Ava, a teenage patient with diabetes, through the halls of Children’s Hospital Los Angeles, hoping to engage her in a conversation about clinical trials. Ava, a teenager with diabetes, and Zippy the research robot “Keep your research studies to yourself!” Ava say…
Lecturers examined the FDA's regulatory requirements for the monitoring, detection, assessment, and safety reporting of adverse effects of drugs, devices, and other medical products.
A seminar co-sponsored by the SC CTSI and Keck School of Medicine showed researchers how to think like a reviewer and write better proposals.
The unexpected findings suggest that people with bad cases of the common skin condition are 36 percent more likely to attempt suicide, suggesting heightened focus by dermatology providers on related psychiatric concerns.
NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.